C
NexgenRx Inc. NEGXF
$0.20 $0.00351.78%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 369.53% -93.19% 220.01% -192.21% -1,423.44%
Total Depreciation and Amortization -3.57% -0.42% 0.98% -2.46% -4.15%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -18.29% -15.49% -109.79% 1,467.92% 40.45%
Change in Net Operating Assets -148.88% 148.88% -455.96% -30.91% 74.36%
Cash from Operations -86.53% 284.56% -233.69% -44.72% 14.99%
Capital Expenditure 75.11% -64.23% -57.47% 78.09% -845.24%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 53.31% -200.00% -- -- --
Cash from Investing 57.54% -158.57% -416.09% 78.09% 69.86%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -9.96% -16.43% 24.18% -57.80% 0.00%
Issuance of Common Stock -- -- -- -100.00% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 91.46% -1,056.33% 92.04% -1,150.81% 92.09%
Other Financing Activities -200.00% -- -- -- --
Cash from Financing 92.05% -623.25% 116.14% -3,702.20% 102.81%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -92.16% 185.70% -759.55% -108.94% 12,661.54%
Weiss Ratings